Kuros Biosciences AG (KURN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Kuros Biosciences AG (KURN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7486
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kuros Biosciences AG (Kuros Biosciences) is a developer of products for tissue repair and regeneration. It develops a family of bone healing products to address indications in trauma and spine called orthobiologics. It is focused on bone repair for trauma, specifically fracture repair, as well as on spinal fusion. Its pipeline of products are being developed for spinal fusion, fracture repair and as surgical sealants. Kuros Biosciences uses a synthetic matrix technology with reliable and pressure resistant, rapid closure of the damaged tissues. The company’s lead sealant product is Neuroseal (KUR-023) developed as an adjunct to suturing for sealing of the dura after cranial surgery. Kuros Biosciences is headquartered in Schlieren, Switzerland.

Kuros Biosciences AG (KURN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kuros Biosciences AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kuros Biosciences AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Kuros Biosciences AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kuros Biosciences AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Kuros Biosciences AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Kuros Biosciences AG, Medical Equipment, Deal Details 10
Venture Financing 10
Kuros Biosurgery Raises Additional USD5 Million Financing 10
Kuros Biosurgery Raises USD15.34 Million in Venture Financing 11
Merger 13
Cytos Biotech Merges with Kuros Biosurgery 13
Equity Offering 14
Kuros Biosciences to Raise up to USD30.2 Million in Private Placement of Shares 14
Kuros Biosciences Raises Funds through Rights Offering of Shares 15
Kuros Biosciences Raises Funds through Public Offering of Shares 16
Acquisition 17
Kuros Biosciences Acquires Xpand Biotech 17
Kuros Biosciences AG – Key Competitors 18
Kuros Biosciences AG – Key Employees 19
Kuros Biosciences AG – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Sep 05, 2018: Kuros Biosciences announces results for first half 2018 21
Apr 30, 2018: Kuros Biosciences Reports Full-Year 2017 Results 22
Apr 26, 2017: Kuros Biosciences Reports Financial Results for 2016 23
Corporate Communications 25
Aug 23, 2018: Kuros Biosciences names Pascal Longlade as chief medical officer 25
May 31, 2018: Kuros Biosciences to Propose Appointment of New Board Members at AGM 26
Dec 14, 2017: Kuros Biosciences Announces Management Succession 27
Nov 28, 2017: Kuros Biosciences’ Chief Medical Officer to Retire 28
Nov 16, 2017: Kuros announces management changes 29
Apr 28, 2017: Kuros Biosciences Proposes Election of Four New Board Members 30
Apr 13, 2017: Kuros announces CEO succession 31
Legal and Regulatory 32
Feb 08, 2017: Kuros achieves ISO certification for surgical sealants 32
Product News 33
Mar 12, 2018: Kuros Biosciences obtains European patent covering osteoinductive materials 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Kuros Biosciences AG, Medical Equipment, Key Facts, 2017 2
Kuros Biosciences AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Kuros Biosciences AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kuros Biosciences AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Kuros Biosciences AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kuros Biosciences AG, Deals By Market, 2012 to YTD 2018 8
Kuros Biosciences AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Kuros Biosurgery Raises Additional USD5 Million Financing 10
Kuros Biosurgery Raises USD15.34 Million in Venture Financing 11
Cytos Biotech Merges with Kuros Biosurgery 13
Kuros Biosciences to Raise up to USD30.2 Million in Private Placement of Shares 14
Kuros Biosciences Raises Funds through Rights Offering of Shares 15
Kuros Biosciences Raises Funds through Public Offering of Shares 16
Kuros Biosciences Acquires Xpand Biotech 17
Kuros Biosciences AG, Key Competitors 18
Kuros Biosciences AG, Key Employees 19
Kuros Biosciences AG, Subsidiaries 20

List of Figures
Kuros Biosciences AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Kuros Biosciences AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Kuros Biosciences AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Kuros Biosciences AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Kuros Biosciences AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kuros Biosciences AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Kuros Biosciences AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kuros Biosciences AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Kuros Biosciences AG (KURN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EOG Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    EOG Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary EOG Resources Inc (EOG) is an independent upstream oil and gas company. The company, along with its subsidiaries, explores for, develops and produces crude oil and natural gas. EOG has operations i …
  • Blueprint Medicines Corp (BPMC):企業の財務・戦略的SWOT分析
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, discovers and develops precision therapies for the treatment of cancers and rare diseases. The company offers AYVAKIT (avapritinib) medicine to treat gastrointestinal stromal tumor (GIST); and GAVRETO (pralse …
  • United Technologies Corp (UTX):電力:M&Aディール及び事業提携情報
    Summary United Technologies Corp (UTC) is a provider of technology products and services for applications in the aerospace and building systems industries. The company’s building systems portfolio includes elevators and escalators, moving walkways, heating, ventilating, air conditioning (HVAC) and r …
  • Kao Corporation:企業の戦略・SWOT・財務情報
    Kao Corporation - Strategy, SWOT and Corporate Finance Report Summary Kao Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Assore Limited:企業の戦略・SWOT・財務分析
    Assore Limited - Strategy, SWOT and Corporate Finance Report Summary Assore Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • L Brands Inc:戦略・SWOT・企業財務分析
    L Brands Inc - Strategy, SWOT and Corporate Finance Report Summary L Brands Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • FMR LLC:企業の戦略的SWOT分析
    FMR LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Abu Dhabi National Oil Co:企業の戦略的SWOT分析
    Abu Dhabi National Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Zynex Inc (ZYXI):企業の財務・戦略的SWOT分析
    Summary Zynex Inc (Zynex), formerly Zynex Medical Inc is a medical technology company that designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. The company’s products include NexWave, a dual channel, multi-modality interferential current, tra …
  • Saga plc:企業の戦略・SWOT・財務情報
    Saga plc - Strategy, SWOT and Corporate Finance Report Summary Saga plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Lyft Inc (LYFT)
    Lyft Inc (LYFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Max India Ltd:企業のM&A・事業提携・投資動向
    Max India Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Max India Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Nisshin Seifun Group Inc:企業の戦略・SWOT・財務分析
    Nisshin Seifun Group Inc - Strategy, SWOT and Corporate Finance Report Summary Nisshin Seifun Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Carl Zeiss Meditec AG (AFX):医療機器:M&Aディール及び事業提携情報
    Summary Carl Zeiss Meditec AG (Carl Zeiss Meditec), a division of Carl Zeiss AG, is an integrated medical technology company, which provides visualization solutions for minimally invasive surgical treatments. It operates in the fields of ophthalmology, neuro/ENT surgery and surgical ophthalmology. T …
  • InterSystems Corp:企業の戦略的SWOT分析
    InterSystems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • University of California Irvine:医療機器:M&Aディール及び事業提携情報
    Summary University of California Irvine (UCI), a subsidiary of University of California is a research university which offers undergraduate, graduate, professional degree courses and research programs. Its academic offerings provide courses in the areas of biological sciences, business, engineering, …
  • ERM Power Ltd:企業の戦略的SWOT分析
    ERM Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Gordon Food Service:戦略・SWOT・企業財務分析
    Gordon Food Service - Strategy, SWOT and Corporate Finance Report Summary Gordon Food Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Rumex International Co:製品パイプライン分析
    Summary Rumex International Co (Rumex International) is a medical device company that manufactures and markets precision instruments for ophthalmology and cardiovascular surgery. The company provides products, which include blade holders, forceps, glaucoma instruments, hooks, lasik and lasek instrum …
  • Eramet:企業の戦略・SWOT・財務情報
    Eramet - Strategy, SWOT and Corporate Finance Report Summary Eramet - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆